Skip to main content
. 2022 Jul 8;12:918606. doi: 10.3389/fonc.2022.918606

Figure 4.

Figure 4

Validation of the prognostic and prognostic value of NCAPG2 in glioma. (A–C) Validation of the prognosis of NCAPG2 in glioma by CGGA, Rembrandt and Gravendeel datasets (D–F) ROC analyses revealed the predictive value of NCAPG2 in glioma based on CGGA, Rembrandt and Gravendeel datasets.